Behr MA - Search Results

1

Lessons From Bacille Calmette-Guérin for SARS-CoV-2 Vaccine Candidates.

Behr MA, Divangahi M, Schurr E. Behr MA, et al. J Infect Dis. 2021 Feb 3;223(2):189-191. doi: 10.1093/infdis/jiaa637. J Infect Dis. 2021. PMID: 33535239 Free PMC article.

2

Correlation between BCG genomics and protective efficacy.

Behr MA. Behr MA. Scand J Infect Dis. 2001;33(4):249-52. doi: 10.1080/003655401300077180. Scand J Infect Dis. 2001. PMID: 11345214 Review.

3

BCG--different strains, different vaccines?

Behr MA. Behr MA. Lancet Infect Dis. 2002 Feb;2(2):86-92. doi: 10.1016/s1473-3099(02)00182-2. Lancet Infect Dis. 2002. PMID: 11901655 Review.

4

Deletion of RD1 from Mycobacterium tuberculosis mimics bacille Calmette-Guérin attenuation.

Lewis KN, Liao R, Guinn KM, Hickey MJ, Smith S, Behr MA, Sherman DR. Lewis KN, et al. Among authors: behr ma. J Infect Dis. 2003 Jan 1;187(1):117-23. doi: 10.1086/345862. Epub 2002 Dec 2. J Infect Dis. 2003. PMID: 12508154 Free PMC article.

5

Crohn's disease, mycobacteria, and NOD2.

Behr MA, Semret M, Poon A, Schurr E. Behr MA, et al. Lancet Infect Dis. 2004 Mar;4(3):136-7. doi: 10.1016/S1473-3099(04)00935-1. Lancet Infect Dis. 2004. PMID: 14998497 No abstract available.

6

Impact of methoxymycolic acid production by Mycobacterium bovis BCG vaccines.

Belley A, Alexander D, Di Pietrantonio T, Girard M, Jones J, Schurr E, Liu J, Sherman DR, Behr MA. Belley A, et al. Among authors: behr ma. Infect Immun. 2004 May;72(5):2803-9. doi: 10.1128/IAI.72.5.2803-2809.2004. Infect Immun. 2004. PMID: 15102790 Free PMC article.

7

Mycobacteria in Crohn's disease: a persistent hypothesis.

Behr MA, Schurr E. Behr MA, et al. Inflamm Bowel Dis. 2006 Oct;12(10):1000-4. doi: 10.1097/01.mib.0000228183.70197.dd. Inflamm Bowel Dis. 2006. PMID: 17012971 Review.

8

Rv1773 is a transcriptional repressor deleted from BCG-Pasteur.

Alexander DC, Behr MA. Alexander DC, et al. Among authors: behr ma. Tuberculosis (Edinb). 2007 Sep;87(5):421-5. doi: 10.1016/j.tube.2007.05.016. Epub 2007 Jul 31. Tuberculosis (Edinb). 2007. PMID: 17669688

9

NOD2-deficient mice have impaired resistance to Mycobacterium tuberculosis infection through defective innate and adaptive immunity.

Divangahi M, Mostowy S, Coulombe F, Kozak R, Guillot L, Veyrier F, Kobayashi KS, Flavell RA, Gros P, Behr MA. Divangahi M, et al. Among authors: behr ma. J Immunol. 2008 Nov 15;181(10):7157-65. doi: 10.4049/jimmunol.181.10.7157. J Immunol. 2008. PMID: 18981137

10

Increased NOD2-mediated recognition of N-glycolyl muramyl dipeptide.

Coulombe F, Divangahi M, Veyrier F, de Léséleuc L, Gleason JL, Yang Y, Kelliher MA, Pandey AK, Sassetti CM, Reed MB, Behr MA. Coulombe F, et al. Among authors: behr ma. J Exp Med. 2009 Aug 3;206(8):1709-16. doi: 10.1084/jem.20081779. Epub 2009 Jul 6. J Exp Med. 2009. PMID: 19581406 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

259 results

Search Page